In this 3-year , randomized , double-blind , placebo-controlled study , 310 adult patients on a regimen of pioglitazone ( with or without metformin ) were randomly assigned to receive additional treatment with albiglutide [ 30 mg subcutaneous ( s.c. ) once weekly , n = 155 ] or matching placebo ( n = 155 ) .